0.9499
+0.0436
+(4.81%)
At close: 4:00:01 PM EDT
0.9605
+0.01
+(1.12%)
After hours: 5:51:47 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | -0.28 | -0.27 | -1.09 | -1 |
| Low Estimate | -0.4 | -0.42 | -1.51 | -1.46 |
| High Estimate | -0.22 | -0.21 | -0.84 | -0.62 |
| Year Ago EPS | -0.37 | -0.42 | -1.49 | -1.09 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 1.11M | 1.61M | 5.72M | -- |
| Sales Growth (year/est) | -100.00% | -100.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.45 | -0.41 | -0.42 | -0.32 |
| EPS Actual | -0.37 | -0.42 | -0.33 | -0.37 |
| Difference | 0.08 | -0.01 | 0.09 | -0.05 |
| Surprise % | 17.27% | -1.58% | 20.78% | -16.07% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.28 | -0.27 | -1.09 | -1 |
| 7 Days Ago | -0.23 | -0.21 | -0.94 | -0.96 |
| 30 Days Ago | -0.23 | -0.2 | -0.94 | -0.97 |
| 60 Days Ago | -0.23 | -0.2 | -0.94 | -0.97 |
| 90 Days Ago | -0.23 | -0.2 | -0.94 | -0.97 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 2 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | 2 | 1 | -- | 1 |
| Down Last 30 Days | 2 | 1 | 3 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| STTK | 23.65% | 35.71% | 26.89% | 8.54% |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Reiterates | Needham: Hold to Hold | 3/27/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/27/2025 |
| Initiated | Leerink Partners: Outperform | 3/17/2025 |
| Reiterates | HC Wainwright & Co.: Neutral | 11/15/2024 |
| Reiterates | Needham: Hold | 11/14/2024 |
| Downgrade | Citigroup: Buy to Neutral | 10/2/2024 |
Related Tickers
ARTV Artiva Biotherapeutics, Inc.
1.9800
+7.61%
LXEO Lexeo Therapeutics, Inc.
1.9800
-8.76%
ABVC ABVC BioPharma, Inc.
0.9140
-12.95%
ENTO Entero Therapeutics, Inc.
0.3899
-3.25%
ONCO Onconetix, Inc.
0.0623
+7.41%
ZVSA ZyVersa Therapeutics, Inc.
0.7700
-0.17%
RLYB Rallybio Corporation
0.2503
-0.12%
CCCC C4 Therapeutics, Inc.
1.2400
+2.48%
BDRX Biodexa Pharmaceuticals Plc
1.7700
+12.74%
VRPX Virpax Pharmaceuticals, Inc.
0.6695
-45.12%